SCHEMBL14725897

SCHEMBL14725897

CC(=O)CCC(=O)NCC(O)CO

nearest known ligand 0.40

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.40
LMNA P02545 3/20 0.37
CYP2C19 P33261 1/20 0.37
HIF1A Q16665 1/20 0.37
SLC15A2 Q16348 1/20 0.34
EGFR P00533 1/20 0.32
SRC P12931 1/20 0.32
ASAH1 Q13510 1/20 0.31
EPHX2 P34913 1/20 0.31
GAA P10253 1/20 0.31
PTPN1 P18031 1/20 0.31
DRD3 P35462 1/20 0.31
SLC6A3 Q01959 1/20 0.31
HPGD P15428 2/20 0.31
KDM4E B2RXH2 1/20 0.31
FAAH O00519 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22815243 0.89 PTPN1 (0.36) ALDH1A1LMNACYP2C19HIF1AASAH1
SCHEMBL20149852 0.89 PTPN1 (0.36) ALDH1A1LMNACYP2C19HIF1AASAH1
SCHEMBL2414889 0.83 LMNA (0.39) ALDH1A1LMNACYP2C19HIF1AEGFR
SCHEMBL22814737 0.82 ALDH1A1 (0.39) ALDH1A1LMNASLC15A2ASAH1EPHX2
SCHEMBL23790740 0.82 PHF8 (0.43) ALDH1A1LMNAPTPN1KDM4EFAAH
SCHEMBL12122298 0.82 CASP2 (0.44) ALDH1A1LMNAASAH1DRD3SLC6A3
SCHEMBL12214348 0.81 NAAA (0.39) ALDH1A1LMNACYP2C19HIF1AEGFR
SCHEMBL27108993 0.79 ALDH1A1 (0.47) ALDH1A1LMNACYP2C19SLC15A2ASAH1
SCHEMBL19431140 0.78 ALDH1A1 (0.47) ALDH1A1LMNACYP2C19HIF1AEPHX2
SCHEMBL12214453 0.78 ALDH1A1 (0.38) ALDH1A1LMNACYP2C19HIF1AEGFR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20230257827-A1 CONJUGATES AND PREPARATION AND USE THEREOF Suzhou Ribo Life Science Co., Ltd. (CN) 2023-08-17 US disclosed
EP-2382199-B1 KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS GFBIOCHEMICALS LTD (MT) 2016-11-16 EP disclosed
US-20150175568-A1 KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS GFBIOCHEMICALS LIMITED (MT) 2015-06-25 US disclosed
US-8969559-B2 Ketal amide compounds, methods of making, and applications SEGETIS, INC. (US) 2015-03-03 US disclosed
US-20130053564-A1 KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS SEGETIS, INC. (US) 2013-02-28 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20130053564-A1 KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS KAT6A, KAT6B, KAT5 ALDH1A1 983/4885LMNA 2934/4885CYP2C19 1437/4885
US-20150175568-A1 KETAL AMIDE COMPOUNDS, METHODS OF MAKING, AND APPLICATIONS KAT6A, KAT6B, KAT5 ALDH1A1 983/4885LMNA 2934/4885CYP2C19 1437/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.